drugset / Trial / NCT06954740
Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury
NaSingle-groupOpen-labelTreatment
Summary
This trial is to evaluate the efficacy and safety of Amimestrocel (human umbilical cord mesenchymal stromal cells) in the treatment of AKI patients.
Timeline
- Start
- 2025-06-10
- Primary completion
- 2026-08-15
- Completion
- 2028-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amimestrocel | Cell therapy | 1e+06 cells/kg | Intravenous |